FDA issues edentate disodium drug warning

Jan 17, 2008

The U.S. Food and Drug Administration said two drugs with similar names, both containing edetate disodium, might be mistaken for each other.

The FDA warned healthcare professionals and patients there have been cases in which children and adults have died when mistakenly given edetate disodium instead of edetate calcium disodium, or when edetate disodium was used for chelation therapy and other uses that aren't approved by the FDA.

Edetate disodium was approved as an emergency treatment for certain patients with very high levels of calcium in their blood or certain patients with heart rhythm problems as a result of very high amounts of digitalis in their blood.

Edetate calcium disodium was approved to treat lead poisoning.

The FDA noted the two drugs have very similar names and are commonly referred to only as EDTA. As a result, officials said the two products are easily mistaken for each other when prescribing, dispensing, and administering them.

Edetate disodium and edetate calcium disodium work by binding with heavy metals or minerals in the body allowing them to be passed through the urine.

The FDA said it is in the process of evaluating the risks and benefits of edetate disodium.

Copyright 2008 by United Press International

Explore further: US appeals court upholds delay in Alzheimer's drug swap

Related Stories

California farmers agree to drastically cut water use

3 hours ago

California farmers who hold some of the state's strongest water rights avoided the threat of deep mandatory cuts when the state accepted their proposal to voluntarily reduce consumption by 25 percent amid ...

Apple may deliver ways to rev up the iPad, report says

4 hours ago

MacRumors last month said that the latest numbers from market research firm IDC's Worldwide Quarterly Tablet Tracker revealed Apple stayed on as the largest vendor in a declining tablet market. The iPad ...

Architects to hatch Ecocapsule as low-energy house

19 minutes ago

Where people call home depends on varied factors, from poverty level to personal philosophy to vanity to community pressure. Ecocapsule appears to be the result of special factors, a team of architects applying ...

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

May 22, 2015

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.